skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: In many of the ETFs that track US healthcare, some of the sub-sectors took a hit yesterday while others outperformed. Is it too early to tell what this portends? Given the new U.S. admin, I’d be grateful if you could share your thoughts on your favourites in this space, especially among the broadly diversified ones. Thanks very much.
Read Answer Asked by Brian on November 11, 2016
Q: Hi, Any comments/significance of following news.

Savaria President and CFO Exercise their Warrants
10:19 EST Wednesday, November 09, 2016
LAVAL, QUEBEC--(Marketwired - Nov. 9, 2016) - Savaria Corporation (TSX:SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, announces that a company wholly owned by Marcel Bourassa, President and Chief Executive Officer of Savaria and Jean-Marie Bourassa, Chief Financial Officer of Savaria, has exercised 500,000 warrants to acquire an equivalent number of common shares of Savaria at a price of $4.25 per share. Savaria will receive gross proceeds of $2,125,000 from the issuance of the shares.

The warrants were issued in connection with a bought deal private placement completed on April 15, 2014, and were set to expire on April 15, 2017. As of today, 1,004,750 warrants have been exercised, representing 35% of the 2,875,000 warrants issued in connection with the 2014 private placement.

Savaria now has 36,350,197 common shares issued and outstanding. Combined, Marcel and Jean-Marie Bourassa hold, directly and indirectly, 14,874,022 shares, representing 40.9% of the Corporation's issued and outstanding common shares.
Read Answer Asked by rajeev on November 09, 2016
Q: I got into CRH after reading your comments on it (and other reports on the website), and added more before the earnings report, so kudos to you. Now that the stock has moved up so much, however, I am trying to figure out how one can tell if it has moved up too much, too fast. My question, then, is how do you tell when it is overvalued?

I know this is a difficult question for a stock that is small, with high growth, and depends on acquisitions, but nonetheless, one has to make decisions and I am struggling with it. I only have a half position in this, so its not a huge risk for me, and I love to watch the daily moves and growth in cash flow.......but I don't want to be married to any stock beyond all reason. Your thoughts would be appreciated.
Read Answer Asked by arnold on November 09, 2016
Q: I'd like to start a long term position in at least one or two healthcare stocks or ETFs, but the sector looks treacherous and I can't quite decide. I'm considering a wide range of names, including companies like JNJ, PFE, AMGN, NVO, NVS, RHHBY, MDT and ETFs like XLV, IBB and especially IHI (medical devices). I've read many of your prior comments, including one where you recommended AMGN. In light of the latest news about AMGN and its issues with Enbrel, I'm curious to know if your opinion has changed, and how you might compare it to NVS which has a competing drug. Mainly I'm wondering if any of the investments I listed sound promising, and how you might rank them. Thanks very much for your thoughts.
Read Answer Asked by Brian on November 01, 2016
Q: How do you think biotech will behave with the looked for Clinton win? Do you think a better buying opportunity is in the future?

TIA
Read Answer Asked by Gerald on November 01, 2016
Q: Good morning Peter and Team,

In our accounts (Margin, RRIF, RRSP, and two TFSAs), we have no health care stocks or ETFs per se, but we do have a 1.8% position in Chartwell. In my sector breakdown, I classified Chartwell as "Real Estate", and notice that in your answers to other 5i members, you refer to Chartwell as a health care stock. Would I be correct in re-classifying CSH.UN as health care? If I wish to further reduce my overweight real estate holdings which contain AP.UN, CIG, CSH.UN, FCR, FSV, and TCN, would there be any that I should "let go" or reduce? What "additional" health care stock or ETF would you recommend at this time, using the cash that the sale/reduction of the above stocks would provide? Please feel free to deduct as many credits as this lengthy question entails, and thanks for the great help your service provides.
Read Answer Asked by Jerry on October 27, 2016
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!